First Header Logo Second Header Logo

Connection

Haodong Xu to Neuroendocrine Tumors

This is a "connection" page, showing publications Haodong Xu has written about Neuroendocrine Tumors.
Connection Strength

0.726
  1. Findeis-Hosey JJ, Xu H. Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer. Biotech Histochem. 2012 Jan; 87(1):24-9.
    View in: PubMed
    Score: 0.387
  2. Ye B, Cappel J, Findeis-Hosey J, McMahon L, Yang Q, Xiao GQ, Xu H, Li F. hASH1 is a specific immunohistochemical marker for lung neuroendocrine tumors. Hum Pathol. 2016 Feb; 48:142-7.
    View in: PubMed
    Score: 0.129
  3. Desouki MM, Lioyd J, Xu H, Cao D, Barner R, Zhao C. CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary. Hum Pathol. 2013 Nov; 44(11):2536-41.
    View in: PubMed
    Score: 0.112
  4. Li F, Ye B, Hong L, Xu H, Fishbein MC. Epigenetic modifications of histone h4 in lung neuroendocrine tumors. Appl Immunohistochem Mol Morphol. 2011 Oct; 19(5):389-94.
    View in: PubMed
    Score: 0.098
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.